Levonordefrin
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Identifiers | |
| CAS number | 829-74-3 |
| ATC code | None |
| PubChem | CID 164739 |
| IUPHAR ligand | 508 |
| DrugBank | DB06707 |
| ChemSpider | 144416 |
| UNII | V008L6478D |
| KEGG | D02388 |
| ChEMBL | CHEMBL677 |
| Chemical data | |
| Formula | C9H13NO3 |
| Mol. mass | 183.204g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Levonordefrin (Nordefrin, Neo-Cobefrin), also known as α-methylnorepinephrine (α-Me-NE), is a sympathomimetic amine used as a topical nasal decongestant and vasoconstrictor in dentistry.[1] It is also a metabolite of the antihypertensive drug methyldopa, and plays a crucial role in its pharmacology and therapeutic benefits.
[edit] See also
[edit] References
[edit] External links
|
|
|
|
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |

